Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!

Biosimilar medicines have shown similarity with the originator biologic and offer a similar clinical outcome generally at a lower cost. This paper identifies benefits of off-patent biologics and biosimilars, and illustrates these benefits with empirical data from Europe. We provide a narrative revie...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Binita, Huys, Isabelle, Vulto, Arnold G., Simoens, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113204/
https://www.ncbi.nlm.nih.gov/pubmed/31792843
http://dx.doi.org/10.1007/s40259-019-00395-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113204/
https://www.ncbi.nlm.nih.gov/pubmed/31792843
http://dx.doi.org/10.1007/s40259-019-00395-w

Ejemplares similares